Amino acid variations of cytochrome P-450 lanosterol 14α-demethylase (CYP51A1) from fluconazole-resistant clinical isolates of Candida albicans

Elias K. Manavathu, Srinivasu Kallakuri, María T. Arganoza, Jose Antonio Vazquez

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We studied six clinical isolates of Candida albicans. All six isolates showed high level resistance to fluconazole (minimum inhibitory concentrations 64 μg/ml) with varying degrees of cross-resistance to other azoles but not to amphotericin B. Neither higher dosage nor upregulation of the gene encoding the cytochrome P450 lanosterol 14 α-demethylase (CYP51A1 or P-450LDM) was responsible for fluconazole resistance. The resistant and the susceptible isolates accumulated similar amounts of azoles. To examine whether resistance to fluconazole in these clinical isolates of C. albicans is mediated by an altered target of azole action, we cloned the structural gene encoding P-450LDM from the fluconazole-resistant isolates. The amino acid sequences of the P-450LDMs from the isolates were deduced from the gene sequences and compared to the P-450LDM sequence of the fluconazole- susceptible C. albicans B311. The enzymes from the clinical isolates showed 2 to 7 amino acid variations scattered across the molecules encompassing 10 different loci. One-half of the amino acid changes obtained were conserved substitutions (E116D, K143R, E266D, D278E, R287K) compared to the susceptible strain. Non-conserved substitutions were T128K, R267H, S405F, G450E and G464S, three of which are in and around the heme-binding region of the molecule. R287K is the only amino acid change that was found in all six clinical isolates. One or more of these mutational alterations may lead to the expression of an azole-resistant enzyme.

Original languageEnglish (US)
Pages (from-to)198-203
Number of pages6
JournalRevista Iberoamericana de Micologia
Volume16
Issue number4
StatePublished - Dec 1 1999

Fingerprint

Lanosterol
Fluconazole
Azoles
Candida albicans
Cytochrome P-450 Enzyme System
Amino Acids
Genes
Microbial Sensitivity Tests
Amphotericin B
Enzymes
Heme
Amino Acid Sequence
Up-Regulation

Keywords

  • C. albicans
  • Demethylase
  • Fluconazole
  • Resistance

ASJC Scopus subject areas

  • Microbiology
  • Infectious Diseases

Cite this

Amino acid variations of cytochrome P-450 lanosterol 14α-demethylase (CYP51A1) from fluconazole-resistant clinical isolates of Candida albicans. / Manavathu, Elias K.; Kallakuri, Srinivasu; Arganoza, María T.; Vazquez, Jose Antonio.

In: Revista Iberoamericana de Micologia, Vol. 16, No. 4, 01.12.1999, p. 198-203.

Research output: Contribution to journalArticle

@article{45eebe0d871541d09a43251aaf785b17,
title = "Amino acid variations of cytochrome P-450 lanosterol 14α-demethylase (CYP51A1) from fluconazole-resistant clinical isolates of Candida albicans",
abstract = "We studied six clinical isolates of Candida albicans. All six isolates showed high level resistance to fluconazole (minimum inhibitory concentrations 64 μg/ml) with varying degrees of cross-resistance to other azoles but not to amphotericin B. Neither higher dosage nor upregulation of the gene encoding the cytochrome P450 lanosterol 14 α-demethylase (CYP51A1 or P-450LDM) was responsible for fluconazole resistance. The resistant and the susceptible isolates accumulated similar amounts of azoles. To examine whether resistance to fluconazole in these clinical isolates of C. albicans is mediated by an altered target of azole action, we cloned the structural gene encoding P-450LDM from the fluconazole-resistant isolates. The amino acid sequences of the P-450LDMs from the isolates were deduced from the gene sequences and compared to the P-450LDM sequence of the fluconazole- susceptible C. albicans B311. The enzymes from the clinical isolates showed 2 to 7 amino acid variations scattered across the molecules encompassing 10 different loci. One-half of the amino acid changes obtained were conserved substitutions (E116D, K143R, E266D, D278E, R287K) compared to the susceptible strain. Non-conserved substitutions were T128K, R267H, S405F, G450E and G464S, three of which are in and around the heme-binding region of the molecule. R287K is the only amino acid change that was found in all six clinical isolates. One or more of these mutational alterations may lead to the expression of an azole-resistant enzyme.",
keywords = "C. albicans, Demethylase, Fluconazole, Resistance",
author = "Manavathu, {Elias K.} and Srinivasu Kallakuri and Arganoza, {Mar{\'i}a T.} and Vazquez, {Jose Antonio}",
year = "1999",
month = "12",
day = "1",
language = "English (US)",
volume = "16",
pages = "198--203",
journal = "Revista Iberoamericana de Micologia",
issn = "1130-1406",
publisher = "Asociacion Espanola de Micologia",
number = "4",

}

TY - JOUR

T1 - Amino acid variations of cytochrome P-450 lanosterol 14α-demethylase (CYP51A1) from fluconazole-resistant clinical isolates of Candida albicans

AU - Manavathu, Elias K.

AU - Kallakuri, Srinivasu

AU - Arganoza, María T.

AU - Vazquez, Jose Antonio

PY - 1999/12/1

Y1 - 1999/12/1

N2 - We studied six clinical isolates of Candida albicans. All six isolates showed high level resistance to fluconazole (minimum inhibitory concentrations 64 μg/ml) with varying degrees of cross-resistance to other azoles but not to amphotericin B. Neither higher dosage nor upregulation of the gene encoding the cytochrome P450 lanosterol 14 α-demethylase (CYP51A1 or P-450LDM) was responsible for fluconazole resistance. The resistant and the susceptible isolates accumulated similar amounts of azoles. To examine whether resistance to fluconazole in these clinical isolates of C. albicans is mediated by an altered target of azole action, we cloned the structural gene encoding P-450LDM from the fluconazole-resistant isolates. The amino acid sequences of the P-450LDMs from the isolates were deduced from the gene sequences and compared to the P-450LDM sequence of the fluconazole- susceptible C. albicans B311. The enzymes from the clinical isolates showed 2 to 7 amino acid variations scattered across the molecules encompassing 10 different loci. One-half of the amino acid changes obtained were conserved substitutions (E116D, K143R, E266D, D278E, R287K) compared to the susceptible strain. Non-conserved substitutions were T128K, R267H, S405F, G450E and G464S, three of which are in and around the heme-binding region of the molecule. R287K is the only amino acid change that was found in all six clinical isolates. One or more of these mutational alterations may lead to the expression of an azole-resistant enzyme.

AB - We studied six clinical isolates of Candida albicans. All six isolates showed high level resistance to fluconazole (minimum inhibitory concentrations 64 μg/ml) with varying degrees of cross-resistance to other azoles but not to amphotericin B. Neither higher dosage nor upregulation of the gene encoding the cytochrome P450 lanosterol 14 α-demethylase (CYP51A1 or P-450LDM) was responsible for fluconazole resistance. The resistant and the susceptible isolates accumulated similar amounts of azoles. To examine whether resistance to fluconazole in these clinical isolates of C. albicans is mediated by an altered target of azole action, we cloned the structural gene encoding P-450LDM from the fluconazole-resistant isolates. The amino acid sequences of the P-450LDMs from the isolates were deduced from the gene sequences and compared to the P-450LDM sequence of the fluconazole- susceptible C. albicans B311. The enzymes from the clinical isolates showed 2 to 7 amino acid variations scattered across the molecules encompassing 10 different loci. One-half of the amino acid changes obtained were conserved substitutions (E116D, K143R, E266D, D278E, R287K) compared to the susceptible strain. Non-conserved substitutions were T128K, R267H, S405F, G450E and G464S, three of which are in and around the heme-binding region of the molecule. R287K is the only amino acid change that was found in all six clinical isolates. One or more of these mutational alterations may lead to the expression of an azole-resistant enzyme.

KW - C. albicans

KW - Demethylase

KW - Fluconazole

KW - Resistance

UR - http://www.scopus.com/inward/record.url?scp=0033369251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033369251&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 198

EP - 203

JO - Revista Iberoamericana de Micologia

JF - Revista Iberoamericana de Micologia

SN - 1130-1406

IS - 4

ER -